Product labeling accuracy and contamination analysis of commercially available cannabidiol product samples
Background and objective: Commercially available cannabidiol (CBD) products are increasingly being used for medicinal purposes, including for the treatment of various neurological conditions, but there are growing concerns around adherence to quality control measures that protect consumers. This stu...
Main Authors: | Barry E. Gidal, Ryan Vandrey, Chela Wallin, Sean Callan, Alan Sutton, Timothy B. Saurer, Jennifer L. Triemstra |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-03-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2024.1335441/full |
Similar Items
-
A comparison of advertised versus actual cannabidiol (CBD) content of oils, aqueous tinctures, e-liquids and drinks purchased in the UK
by: Drusus A. Johnson, et al.
Published: (2023-07-01) -
The Safety and Effectiveness of Commercially Available Cannabidiol Products for Health and Well-Being: A Randomized, Multi-Arm, Open-Label Waitlist-Controlled Trial
by: Jessica Londeree Saleska, et al.
Published: (2022-11-01) -
Cure-All cannabidiol? The cannabidiol content of commercial products
by: Michaela Mouton, et al.
Published: (2024-02-01) -
An Authentication Survey on Retail Seafood Products Sold on the Bulgarian Market Underlines the Need for Upgrading the Traceability System
by: Lara Tinacci, et al.
Published: (2023-03-01) -
Product Authentication Using Two Mitochondrial Markers Reveals Inconsistent Labeling and Substitution of Canned Tuna Products in the Taiwanese Market
by: Chia-Hao Chang, et al.
Published: (2021-11-01)